Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients

被引:242
作者
Galotto, M
Berisso, G
Delfino, L
Podesta, M
Ottaggio, L
Dallorso, S
Dufour, C
Ferrara, GB
Abbondandolo, A
Dini, G
Bacigalupo, A
Cancedda, R
Quarto, R
机构
[1] Ist Nazl Ric Canc, Ctr Biotecnol Avanzate, Lab Differenziamento Cellulare, I-16132 Genoa, Italy
[2] Osped San Martino Genova, Div Ematol, Genoa, Italy
[3] Ist Giannina Gaslini, Div Ematooncol Pediat & Trapianto Midollo Osseo, I-16148 Genoa, Italy
[4] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy
关键词
bone marrow transplant; CFU-f; LTC-IC;
D O I
10.1016/S0301-472X(99)00076-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone marrow transplant (BMT) relies on the engraftment of donor hemopoietic precursors in the host marrow space. Colony forming units-fibroblasts (CFU-f), the precursor compartment for the osteogenic lineage, are essential to hemopoietic stem cell survival, proliferation and differentiation. We have studied CFU-f in donors (aged 5 months to 62 years) and in patients who had received allogeneic BMT (aged 2 months to 63 years). In donor marrows we found an inverse correlation between CFU-f frequency and age. In BMT recipients CFU-f frequencies were reduced by 60%-90% (p < 0.05) and the numbers did not recover up to 12 years after transplant. Stromal reconstitution to normal levels was found only in patients < 5 Sears old, In all patients studied CFU-f post-BMT were of host origin. Patients with low CFU-f levels displayed also a decreased bone mineral density (p < 0.05) and significantly reduced levels of long-term culture-initiating cells (LTC-IC) (p < 0.05). Our study demonstrates that the marrow stromal microenvironment is seriously and irreversibly damaged after BMT. Donor cells do not contribute to reconstitute the marrow microenvironment, whose residual CFU-fs remain of host origin. (C) 1999 International Society for Experimental Hematology, Published by Elsevier Science Inc.
引用
收藏
页码:1460 / 1466
页数:7
相关论文
共 45 条
  • [1] RECIPIENT ORIGIN OF BONE MARROW-DERIVED FIBROBLASTIC STROMAL CELLS DURING ALL PERIODS FOLLOWING BONE-MARROW TRANSPLANTATION IN HUMANS
    AGEMATSU, K
    NAKAHORI, Y
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (03) : 359 - 365
  • [2] Allen T D, 1990, Immunol Ser, V49, P1
  • [3] BENNETT JH, 1991, J CELL SCI, V99, P131
  • [4] BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270
  • [5] MESENCHYMAL STEM-CELLS
    CAPLAN, AI
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) : 641 - 650
  • [6] Reduction of bone mass in women after bone marrow transplantation
    Castaneda, S
    Carmona, L
    Carvajal, I
    Arranz, R
    Diaz, A
    GarciaVadillo, A
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (04) : 343 - 347
  • [7] CHARBORD P, 1985, BLOOD, V66, P1138
  • [8] Dexter T M, 1984, Kroc Found Ser, V18, P57
  • [9] CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO
    DEXTER, TM
    ALLEN, TD
    LAJTHA, LG
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) : 335 - 344
  • [10] THE NUMBER OF FIBROBLASTIC COLONIES FORMED FROM BONE-MARROW IS DECREASED AND THE INVITRO PROLIFERATION RATE OF TRABECULAR BONE-CELLS INCREASED IN AGED RATS
    EGRISE, D
    MARTIN, D
    VIENNE, A
    NEVE, P
    SCHOUTENS, A
    [J]. BONE, 1992, 13 (05) : 355 - 361